Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to press and analyst briefings

OUTOTEC OYJ   PRESS RELEASE   JUNE 30, 2020 AT 10:00 AM Invitation to press and analyst briefings July 1, 2020 marks the first day of future Metso Outotec, a unique new company with leadership in sustainable minerals processing, metals refining and recycling technologies globally. Combined, the future Metso Outotec will deliver significant benefits for its customers, shareholders and other stakeholders through the comprehensive full plant offering from equipment to a broad range of services, complemented by a large installed base, strong innovation and R&D capabilities and

Immunovia Targeting Long-Term Market Penetration of 30% for IMMray™ PanCan-d

LUND, SWEDEN – Immunovia AB (publ) (“Immunovia”) today announced the company’s long-term market penetration target of 30% for IMMray™ PanCan-d, after reimbursement and widespread insurance coverage is achieved. As previously announced, Immunovia recently secured one of the largest funding raises for an EU-based diagnostics company, providing a strong financial position ahead of the company’s first product launch based on the IMMray™ platform. Immunovia’s first to market product IMMray™[ ]PanCan-d, is a long-sought solution for the unmet need of early and accurate detection of

Redeye: AroCell - Changes to the Case

Redeye significantly raises its Base Case for AroCell, given fundamental changes to the case following recent FDA filing in combination with close discussions with management. The company is transitioning to a more commercially oriented business with anticipated key activities in the coming 6-9 months. At a current market capitalization of roughly SEK 130m, we see great upside in the stock on all horizons. Read more and download the research update  Start following companies at Redeye to receive the latest equity

Change in the number of shares and votes in Q-linea AB

Q-linea AB (publ) (”Q-linea” or ”the Company”), today announced that the number of shares and votes in Q-linea has increased during the month of June due to the direct issue of shares to certain Swedish and international institutional investors and sector specialist investors. The press release regarding the issue of shares was published on 2 June 2020. A total of 4,000,000 ordinary shares and votes have been added. At 30 June 2020, which is the last trading day in June, the number of shares and votes in the Company amounts to 27,337,947. All shares are ordinary shares.   For

SKF announces changes to Group Management

Gothenburg, 30 June 2020: Bernd Stephan, President, Automotive and Aerospace, has stepped down from his role in Group Management for health reasons. Responsibility for Automotive sales and the Aerospace business unit has been assumed on an interim basis by Alrik Danielson, President and CEO. Bernd will support Alrik on an advisory basis, until his retirement from SKF on 31 December 2020. Responsibility for Automotive manufacturing has been moved to Kent Viitanen, President, Bearing Operations. Alrik Danielson says: “I would like to thank Bernd for all that he has done for SKF

Obducat receives order for an EITRE® 8 NIL-system and three lithography tools for resist- and wet processing from a customer in Asia

OBDUCAT AB (publ) subsidiary Obducat Technologies AB and Obducat Europe GmbH, leading suppliers of lithography processing solutions and nanoimprint lithography (NIL) tools, have received orders from a customer in Asia, for the supply of a EITRE 8 NIL-system as well as a coater, developer and cleaner. The order value amounts to approx. 6.6 million SEK.The lithography system will be installed in the cleanroom facilities of the customer where it will be used for development and pilot production primarily focused on optical and photonic components. Obducat was awarded the contracts after

Alelion receives follow-up order from global special vehicle manufacturer Terberg Group worth 8 MSEK

Alelion Energy Systems has received a follow-up order for high voltage batteries from the global special vehicle manufacturer Terberg Group worth 8 MSEK for delivery during 2021. This order is a follow-up to the cooperation agreement and the order from Terberg communicated in October 2018. Along with this order Terberg has also given notice to proceed with battery systems from the original order for delivery during the fourth quarter of this year, which will then have a positive cash flow impact of approximately 5 MSEK.The battery systems will be used for electrification of several of

Change in number of shares and votes in Tethys Oil

Tethys Oil (publ) (“Tethys Oil”) has, in accordance with previously announced information, completed a mandatory share redemption procedure whereby every redemption share in Tethys Oil has been redeemed. In addition, and as previously announced, Tethys Oil has in June cancelled treasury shares repurchased by the company. As a result, the number of shares and votes in Tethys Oil has changed.As at 1 June 2020, the total number of shares and votes amounted to 72,589,920, of which 36,294,960 were ordinary shares and 36,294,960 were redemption shares.  The redemption shares were traded up to

Veidekke ASA: To build for Felleskjøpet at Gardermoen

Veidekke Logistikkbygg has signed a contract with Olav Thon Eiendom (Gardermoen Park AS) for the construction of Felleskjøpet's new central warehouse at Gardermoen. This is a turnkey contract valued at NOK 181 million, excluding VAT.“We are very pleased that Olav Thon Eiendom has chosen us as contractor for a major logistics project. The commission is a perfect fit in our strategy of developing and constructing non-residential buildings under turnkey contracts. We look forward to embarking on the task and to an exciting and fruitful construction process together with Felleskjøpet and Olav

Veoneer Recognized by General Motors as a 2019 Supplier of the Year Winner

Stockholm, Sweden, June 30, 2020:  The automotive technology company Veoneer, Inc. (NYSE: VNE and SSE: VNE SDB), was named a GM Supplier of the Year by General Motors during a virtual ceremony honoring the recipients of the company’s 28[th] annual Supplier of the Year awards on Wednesday, June 24, 2020.During the event, GM recognized 116 of its best suppliers from 15 countries that have consistently exceeded GM’s expectations, created outstanding value or introduced innovations to the company. The awards ceremony was originally scheduled as a live-event to be held in March but was postponed

Nel ASA: Receives purchase order for multiple hydrogen fueling stations

(Oslo, 30 June 2020) Nel Hydrogen Fueling, a division of Nel ASA (Nel, OSE:NEL) has received a purchase order for multiple H2Station™ units from a large international company. "We are honored that the company has chosen to go for our H2Station™ fueling solution, and we look forward to support their fueling station deployment", says Ulrik Torp Svendsen, Key Account Manager, Nel Hydrogen Fueling. The value of the purchase order is in excess of NOK 150 million, and the H2Station™ modules which will be used for fueling of passenger vehicles in an existing market for Nel will be installed

Linxon wins $80 million order for substation project in Iraq funded by Japanese financing institution JICA

Linxon has won an order of around $80 million to the Ministry of Electricity in Iraq for delivery of four turnkey 132/33 kV GIS substations. The contract forms part of the Electricity Sector Reconstruction Project (Phase 2) financed by Japan International Cooperation Agency (JICA).The delivery includes all needed equipment (High Voltage 132 kV GIS, 132/33 kV power transformers, 33 kV switchgear, control & protection system, communication system etc) as well as design, civil construction works, installation and commissioning. The delivery time is 18 months and the project will start around

Divio Technologies genomför riktad nyemission

· Styrelsen i Divio Technologies AB har beslutat att genomföra en riktad nyemission av 11,11 miljoner B-aktier till emissionskursen 0,45 SEK, som tillför bolaget 5 miljoner SEK.  · Nyemissionen ska möjliggöra accelererade försäljningsprocesser mot stora, långsiktigt lönsamma kunder.Jon Levin, VD i Divio Technologies, kommenterar: Vårt fokus är att prioritera försäljningsprocessen mot stora, långsiktigt mer lönsamma kunder. Vi har redan Fidelity och ett antal andra större kunder och vår målsättning är att utveckla samma kundrelation med andra bolag av samma dignitet. Vi tror att vi är på

Flexion Mobile signs Battle Warship from Special Gamez

Another top tier game signing from Flexion's team in ChinaLONDON, 30th of June, 2020 – Flexion Mobile Plc (Nasdaq: FLEXM), the Android games distribution company today announced that it has signed an agreement  with a new developer called Special Gamez for Battle Warship Naval Empire. In May, the top tier game generated USD 3 million net revenue in Google Play according to data analyst Sensor Tower. The game is expected to launch this summer and the agreement covers all Flexion main channels Amazon, Huawei, ONE Store and Samsung.  "This game is a classic naval war game that we have been

Selumetinib granted orphan drug designation in Japan for neurofibromatosis type 1

30 June 2020 07:00 BST Selumetinib granted orphan drug designation in Japan for neurofibromatosis type 1 Designation follows recent US approval with additional regulatory submissions underway Phase II SPRINT trial showed selumetinib reduced tumourvolume in paediatric patients with NF1 plexiform neurofibromas AstraZeneca today announced that selumetinib has been granted orphan drug designation (ODD) in Japan for the treatment of neurofibromatosis type 1 (NF1), a rare and debilitating genetic disease.[1] Selumetinib is co-developed and co-commercialised with MSD Inc.,

New number of shares and votes in Moberg Pharma AB (publ)

STOCKHOLM, June 30[th] 2020. During June 2020, the registered number of shares and votes in Moberg Pharma AB (OMX: MOB) (“Moberg Pharma” or the “Company”) has increased due to conversion of convertible notes issued pursuant to the financing agreement entered into between the Company and Nice & Green S.A. on March 23rd, 2020.The total number of shares and votes in the Company has increased as a result of the board of directors’ resolution to approve Nice & Green S.A.’s request to convert a number of convertible notes into a total of 34,430 common shares in the Company, in accordance with the

MAG Interactive AB (publ) publishes Interim Report September – May 2019/2020

Revenue increases by 34% in Q3 compared to the same quarter the previous yearSummary of the period March 2019 – May 2020: · The Group's net sales for the period were 64,838 KSEK (48,311 KSEK), an increase of 34% compared to the same period the previous year · EBITDA for the period was 3,404 KSEK (542 KSEK) · The Group's game contribution for the period was 30,710 KSEK (27,463 KSEK), an increase of 12% compared to the same period the previous year · Average revenue per daily active user, ARPDAU, for the period was 3.0 US cents (2.6 US cents), an increase of 14% compared to the

SciBase announces a Management team change

Anna Danström, SciBase’s head of production and supply chain, has chosen to leave her position and accept a role at another company. Linn Olsen will replace Anna as production and supply chain manager. Linn has a broad background within production, QA and Medtech, and comes from Trimble.  ”I would like to take the opportunity to thank Anna for her exceptional work at SciBase, and especially at our Uppsala facility. Anna has ensured that we have a well-functioning electrode manufacturing process and team and has also played a key role in improving our electrode gross margin. I wish Anna

Hansa Biopharma to host conference call to provide interim results for the first half of 2020 and business update

Lund, Sweden June 30, 2020. Hansa Biopharma will publish its interim report for January-June 2020 at 8:00 a.m. CET on July 16, 2020. All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at 2:00 p.m. CET. The event will be hosted by Hansa Biopharma’s CEO, Søren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English. Slides used in the presentation will be live on the company website during the call under “Events & Webcast,” and will also be made

Completed transactions and construction starts during the first half of 2020

During the first half of 2020, Wallenstam started the construction of almost 400 apartments in two projects, in Gothenburg and Mölnlycke. In addition, several transactions and agreements were completed that will enable future new production.The construction starts involve 267 rental apartments in Kv.8, part of the urban development project Kallebäcks Terraser in Gothenburg and 116 rental apartments in the Väven block, part of the urban development project Mölnlycke Fabriker in Härryda Municipality. All 383 apartments are planned to be ready for occupation during 2022. In March,

Inhalation Sciences: key patent approved in Europe

(Stockholm, 30 June 2020) Inhalation Sciences (ISAB) has received European approval, with no restrictions, for a key patent that covers the company’s unique simplified method to accomplish so called “regional targeting”— or being able to selectively direct aerosol exposures to the different main regions in the lung.Regional targeting gives new opportunities to map how either drug substances or air pollutants work in the lungs. The patent with reference number EP2173419 has previously been approved in the US and China, but is now also approved on the important European market without

Presentation of Gränges’ half-year report for January–June 2020

Gränges’ half-year report for the period January–June 2020 will be published at 07.30 CEST on Thursday, 16 July 2020. The webcast will be available on www.granges.com/investors. To participate in the conference call, please call +46 8 56642651 (Sweden), +44 3333000804 (United Kingdom) or +1 6319131422 (United States). PIN code: 69788601#. Please call a few minutes before the conference call begins. A presentation will be available on the company’s website before the webcast begins. For further information, please contact:Johan Dufvenmark, VP Group Treasury & Investor Relations

Change in the total number of shares and votes in Recipharm AB (publ)

As of 30 June 2020, the total number of shares in Recipharm AB (publ) (“Recipharm”) amounts to 100,990,187 shares, divided into 21,311,998 shares of series A and 79,678,189 shares of series B. The total number of votes in Recipharm as of 30 June 2020 amounts to 292,798,169. The number of shares and votes in Recipharm has increased as a result of the registration of 6,089,140 shares of series A and 22 600 368 shares of series B subscribed for by the exercise of subscription rights in the ongoing rights issue in Recipharm, which was resolved on May 26, 2020.  For more information

There are no items matching the current filter
There are no more items matching the current filter
Back to top